Biliary complications after liver transplantation

Expert Review of Gastroenterology and Hepatology

Volumn 9, Issue 4, 2015, Pages 447-466

  Nemes, Balázs ^a   Gámán, György ^b   Doros, Attila ^b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Biliary complication; ERCP; Hepatitis C; Intervention; ITBL; Liver transplantation; Overview; Radiology; Surgery; Vanishing bile duct

Indexed keywords

MICRORNA;

BILE DUCT BYPASS; BILE DUCT DISEASE; BILE LEAKAGE; CADAVER DONOR; CHOLESTASIS; COLD ISCHEMIA; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GRAFT REJECTION; HEPATIC ARTERY THROMBOSIS; HEPATITIS B; HEPATITIS C; HUMAN; ISCHEMIC TYPE BILIARY LESION; LIVER TRANSPLANTATION; MACROVESICULAR GRAFT STEATOSIS; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; NEMES DOROS SCORE; NON INVASIVE PROCEDURE; ORGAN DONOR; PLASTIC STENT; POSTOPERATIVE COMPLICATION; PRIMARY SCLEROSING CHOLANGITIS; REVIEW; SCORING SYSTEM; SELF EXPANDABLE METALLIC STENT; STEATOSIS; SUTURE; T TUBE; VANISHING BILE DUCT SYNDROME; VATER PAPILLA STENOSIS; ADVERSE EFFECTS; BILE DUCT DISEASES; END STAGE LIVER DISEASE; REOPERATION; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

BILE DUCT DISEASES; END STAGE LIVER DISEASE; HUMANS; LIVER TRANSPLANTATION; REOPERATION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84924359505     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/17474124.2015.967761     Document Type: Review

References (117)

1. Akamatsu N, Sugawara Y, Hashimoto D. Biliary reconstruction, its complications and management of biliary complications after adult liver transplantation: a systematic review of the incidence, risk factors and outcome. Transpl Int 2011;24(4):379-92
2. Sundaram V, Jones DT, Shah NH, et al. Posttransplant biliary complications in the pre- and post-model for end-stage liver disease era. Liver Transpl 2011;17(4):428-35
3. Gantxegi A, Caralt M, Bilbao I, et al. Evolution of biliary complications after liver transplantation: a single European series. Transplant Proc 2011;43(3):745-8
4. Benitez Cantero JM, Costan Rodero G, Montero Alvarez JL, et al. Biliary complications after liver transplantation using side-to-side choledochocholedochostomy reconstruction with or without T-tube. Transplant Proc 2012;44(7):2098-9
5. Kucera M, Adamec M, Oliverius M, et al. [Early biliary complications following liver transplantation]. Rozhl Chir 2011;90(2):117-21
6. Perrakis A, Fortsch T, Schellerer V, et al. Biliary tract complications after orthotopic liver transplantation: still the " Achilles heel"? Transplant Proc 2010;42(10):4154-7
7. Gastaca M, Matarranz A, Munoz F, et al. Biliary complications in orthotopic liver transplantation using choledochocholedochostomy with a T-tube. Transplant Proc 2012;44(6):1554-6
8. Heidenhain C, Pratschke J, Puhl G, et al. Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. Transpl Int 2010;23(1):14-22
9. Cursio R, Gugenheim J. Ischemia-reperfusion injury and ischemic-type biliary lesions following liver transplantation. J Transplant 2012;2012:164329
10. Buis CI, Geuken E, Visser DS, et al. Altered bile composition after liver transplantation is associated with the development of nonanastomotic biliary strictures. J Hepatol 2009;50(1):69-79
11. Memeo R, Belli A, Kluger MD, et al. Duct-to-duct biliary reconstruction during complex hepatectomy: a useful technique in selected cases. World J Surg 2012;36(1):129-35
12. Neff GW, Shire N, Ruiz P, et al. The importance of clinical parameters when differentiating cholestatic hepatitis C virus from allograft rejection. Transplant Proc 2005;37(10):4397-402
13. Nemes B, Gelley F, Zadori G, et al. Predictive factors of sustained virological response for recurrent hepatitis C virus after liver transplantation: the Hungarian experience. Transplant Proc 2012;44(7):2162-3
14. Pirenne J, Monbaliu D, Aerts R, et al. Biliary strictures after liver transplantation: risk factors and prevention by donor treatment with epoprostenol. Transplant Proc 2009;41(8):3399-402
15. Halme L, Hockerstedt K, Lautenschlager I. Cytomegalovirus infection and development of biliary complications after liver transplantation. Transplantation 2003;75(11):1853-8
16. Inomata Y, Tanaka K. Pathogenesis and treatment of bile duct loss after liver transplantation. J Hepatobiliary Pancreat Surg 2001;8(4):316-22
17. Nader K, Mok S, Kalra A, et al. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature. Tumori 2013;99(4):e164-8
18. Gagnon MF, Nguyen BN, Olney HJ, Lemieux B. Vanishing bile duct syndrome arising in a patient with T-cell-rich large B-cell lymphoma. J Clin Oncol 2013;31(20):e357-9
19. Oppenheimer AP, Koh C, McLaughlin M, et al. Vanishing bile duct syndrome in human immunodeficiency virus infected adults: a report of two cases. World J Gastroenterol 2013;19(1):115-21
20. Kawasaki Y, Matsubara K, Hashimoto K, et al. Nonsteroidal anti-inflammatory drug-induced vanishing bile duct syndrome treated with plasmapheresis. J Pediatr Gastroenterol Nutr 2013;57(5):e30-1
21. Bihl F, Emmenegger U, Reichen J, et al. Macrophage activating syndrome is associated with lobular hepatitis and severe bile duct injury with cholestasis. J Hepatol 2006;44(6):1208-12
22. Gelley F, Gaman G, Gerlei Z, et al. Hepatitis C virus recurrence after liver transplantation in Hungary. Trends over the past 10 years. Orv Hetil 2013;154(27):1058-66
23. Sganga G, Bianco G, Fiori B, et al. Surveillance of bacterial and fungal infections in the postoperative period following liver transplantation: a series from 2005-2011. Transplant Proc 2013;45(7):2718-21
24. Darius T, Rivera J, Fusaro F, et al. Risk factors and surgical management of anastomotic biliary complications after pediatric liver transplantation. Liver Transpl 2014;20(8):893-903
25. Sawyer RG, Punch JD. Incidence and management of biliary complications after 291 liver transplants following the introduction of transcystic stenting. Transplantation 1998;66(9):1201-7
26. Douzdjian V, Abecassis MM, Johlin FC. Sphincter of Oddi dysfunction following liver transplantation. Screening by bedside manometry and definitive manometric evaluation. Dig Dis Sci 1994;39(2):253-6
27. Gholson CF, Zibari G, McDonald JC. Endoscopic diagnosis and management of biliary complications following orthotopic liver transplantation. Dig Dis Sci 1996;41(6):1045-53
28. Rerknimitr R, Sherman S, Fogel EL, et al. Biliary tract complications after orthotopic liver transplantation with choledochocholedochostomy anastomosis: endoscopic findings and results of therapy. Gastrointest Endosc 2002;55(2):224-31
29. Kochhar G, Parungao JM, Hanouneh IA, Parsi MA. Biliary complications following liver transplantation. World J Gastroenterol 2013;19(19):2841-6
30. Balderramo D, Sendino O, Miquel R, et al. Prospective evaluation of single-operator peroral cholangioscopy in liver transplant recipients requiring an evaluation of the biliary tract. Liver Transpl 2013;19(2):199-206
31. Horster S, Bauerlein FJ, Mandel P, et al. Influence of hepatitis C virus infection and high virus serum load on biliary complications in liver transplantation. Transpl Infect Dis 2013;15(3):306-13
32. Gelley F, Zadori G, Nemes B, et al. MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis. J Gastroenterol Hepatol 2014;29(1):121-7
33. Gatto M, Alvaro D. Cholangiocarcinoma: risk factors and clinical presentation. Eur Rev Med Pharmacol Sci 2010;14(4):363-7
34. Kim HY, Cho HK, Choi YH, et al. Bile acids increase hepatitis B virus gene expression and inhibit interferon-alpha activity. Febs j 2010;277(13):2791-802
35. Oehler N, Volz T, Bhadra OD, et al. Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology 2014. [Epub ahead of print]
36. Matsumoto K, Imasato M, Yamazaki Y, et al. Claudin 2 Deficiency Reduces Bile Flow and Increases Susceptibility to Cholesterol Gallstone Disease in Mice. Gastroenterology 2014. [Epub ahead of print]
37. Voigtlander T, Negm AA, Strassburg CP, et al. Biliary cast syndrome post-liver transplantation: risk factors and outcome. Liver Int 2013;33(8):1287-92
38. Anwer MS. Role of protein kinase C isoforms in bile formation and cholestasis. Hepatology 2014;60(3):1090-7
39. Rigopoulou EI, Zachou K, Gatselis NK, et al. Primary biliary cirrhosis in HBV and HCV patients: clinical characteristics and outcome. World J Hepatol 2013;5(10):577-83
40. Manne V, Allen RM, Saab S. Strategies for the prevention of recurrent hepatitis B virus infection after liver transplantation. Gastroenterol Hepatol (N Y) 2014;10(3):175-9
41. Gelley F, Zadori G, Gorog D, et al. Recurrence of primary sclerosing cholangitis after liver transplantation - The Hungarian experience. Interv Med Appl Sci 2014;6(1):16-18
42. Nemes B, Gaman G, Sarvary E, et al. Retransplantations in the Hungarian liver transplant program. Transplant Proc 2013;45(10):3688-90
43. Nemes B, Gaman G, Gelley F, et al. Technical risk factors for hepatic artery thrombosis after orthotopic liver transplantation: the Hungarian experience. Transplant Proc 2013;45(10):3691-4
44. Wojcicki M, Lubikowski J, Klek R, et al. Reduction of biliary complication rate using continuous suture and no biliary drainage for duct-to-duct anastomosis in whole-organ liver transplantation. Transplant Proc 2009;41(8):3126-30
45. Maccagno G, Heise M, Hoppe-Lotichius M, et al. Ischemic-type biliary lesions after liver transplantation: a retrospective analysis of risk factors and outcome. Clin Lab 2013;59(7-8):747-55
46. Lankisch TO, Voigtlander T, Manns MP, et al. MicroRNAs in the bile of patients with biliary strictures after liver transplantation. Liver Transpl 2014;20(6): 673-8
47. Verhoeven CJ, Farid WR, de Ruiter PE, et al. MicroRNA profiles in graft preservation solution are predictive of ischemic-type biliary lesions after liver transplantation. J Hepatol 2013;59(6):1231-8
48. Nemes B, Sótonyi P, Lotz G, et al. Localization of apoptosis proteins and lymphocyte subsets in chronic rejection of human liver allograft. Interventional Medicine and Applied Science 2010;2(2):77-85
49. Kinner S, Dechene A, Ladd SC, et al. Comparison of different MRCP techniques for the depiction of biliary complications after liver transplantation. Eur Radiol 2010; 20(7):1749-56
50. Kim YJ, Lee KT, Jo YC, et al. Hepatobiliary scintigraphy for detecting biliary strictures after living donor liver transplantation. World J Gastroenterol 2011;17(21):2626-31
51. Hsieh TH, Mekeel KL, Crowell MD, et al. Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc 2013;77(1):47-54
52. Londono MC, Balderramo D, Cardenas A. Management of biliary complications after orthotopic liver transplantation: the role of endoscopy. World J Gastroenterol 2008;14(4):493-7
53. Kaffes A, Griffin S, Vaughan R, et al. A randomized trial of a fully covered self-expandable metallic stent versus plastic stents in anastomotic biliary strictures after liver transplantation. Therap Adv Gastroenterol 2014;7(2):64-71
54. Fontein DB, Gibson RN, Collier NA, et al. Two decades of percutaneous transjejunal biliary intervention for benign biliary disease: a review of the intervention nature and complications. Insights Imaging 2011;2(5):557-65
55. Saad WE, Wallace MJ, Wojak JC, et al. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol 2010;21(6):789-95
56. Gwon DI, Sung KB, Ko GY, et al. Dual catheter placement technique for treatment of biliary anastomotic strictures after liver transplantation. Liver Transpl 2011;17(2):159-66
57. Neuhaus P, Blumhardt G, Bechstein WO, et al. Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg 1994;219(4):426-34
58. Paes-Barbosa FC, Massarollo PC, Bernardo WM, et al. Systematic review and meta-analysis of biliary reconstruction techniques in orthotopic deceased donor liver transplantation. J Hepatobiliary Pancreat Sci 2011;18(4):525-36
59. Ushigome H, Sakai K, Suzuki T, et al. Biliary anastomosis and biliary complications following living donor liver transplantation. Transplant Proc 2008;40(8):2537-8
60. Kim BW, Bae BK, Lee JM, et al. Duct-to-duct biliary reconstructions and complications in 100 living donor liver transplantations. Transplant Proc 2009;41(5):1749-55
61. Marubashi S, Dono K, Nagano H, et al. Biliary reconstruction in living donor liver transplantation: technical invention and risk factor analysis for anastomotic stricture. Transplantation 2009;88(9):1123-30
62. Lin TS, Concejero AM, Chen CL, et al. Routine microsurgical biliary reconstruction decreases early anastomotic complications in living donor liver transplantation. Liver Transpl 2009;15(12):1766-75
63. Tsui TY, Schlitt HJ, Obed A. Prospective evaluation of biliary reconstruction with duct-to-duct continuous suture in adult live donor liver transplantation. Langenbecks Arch Surg 2011;396(2):209-15
64. Leonardi MI, Ataide EC, Boin IF, Leonardi LS. Role of choledochojejunostomy in liver transplantation. Transplant Proc 2005;37(2):1126-8
65. Llado L, Fabregat J, Baliellas C, et al. Surgical treatment of biliary tract complications after liver transplantation. Transplant Proc 2012;44(6):1557-9
66. Jang SI, Kim JH, Won JY, et al. Magnetic compression anastomosis is useful in biliary anastomotic strictures after living donor liver transplantation. Gastrointest Endosc 2011;74(5):1040-8
67. Kinner S, Steinweg V, Maderwald S, et al. Bile duct evaluation of potential living liver donors with Gd-EOB-DTPA enhanced MR cholangiography: single-dose, double dose or half-dose contrast enhanced imaging. Eur J Radiol 2014;83(5):763-7
68. Chok KS, Lo CM. Prevention and management of biliary anastomotic stricture in right-lobe living-donor liver transplantation. J Gastroenterol Hepatol 2014. [Epub ahead of print]
69. Gulsen MT, Girotra M, Cengiz-Seval G, et al. HTK preservative solution is associated with increased biliary complications among patients receiving DCD liver transplants: a single center experience. Ann Transplant 2013;18:69-75
70. Stewart ZA, Cameron AM, Singer AL, et al. Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant 2009;9(2):286-93
71. Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg 2011;253(4):817-25
72. Abt P, Crawford M, Desai N, et al. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation 2003;75(10):1659-63
73. Mateo R, Cho Y, Singh G, et al. Risk factors for graft survival after liver transplantation from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant 2006;6(4):791-6
74. Lin TS, Chen CL, Concejero AM, et al. Technical details of microsurgical biliary reconstruction in living donor liver transplantation. Transplantation 2014;97(Suppl 8):S34-6
75. Will U, Meyer F. [Endoscopic ultrasonography (EUS)-guided transluminal cholangiodrainage (EUCD) - a novel option of interventional endoscopy in the interdiciplinary management of obstructive jaundice]. Zentralbl Chir 2012;137(1):20-31
76. Chen G, Wang S, Bie P, et al. Endogenous bile salts are associated with bile duct injury in the rat liver transplantation model. Transplantation 2009;87(3):330-9
77. Hoekstra H, Porte RJ, Tian Y, et al. Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+/- mice. Hepatology 2006;43(5):1022-31
78. Verhoeven C J, Maroni L, Gadjradj P, et al. Fucosyltransferase-2 Non-Secretor status is associated with non-anastomotic biliary strictures after liver transplantation in recipients with primary sclerosing cholangitis. Presented at: 2014 Joint International Congress of ILTS, ELITA &LICAGE. London, UK, 4-7 June 2014
79. den Dries S O, Westerkamp AC, Karimian N, et al. Injury of peribiliary glands and vascular plexus before liver transplantation predicts formation of non-anastomotic biliary strictures. Presented at: Joint International Congress of ILTS, ELITA & LICAGE. London, UK, 4-7 June 2014
80. Kim JM, Kim JH, Lee SY, et al. Prediction of biliary complications after living-donor liver transplantation based on serum cytokine profile. Transplant Proc 2014;46(3):861-4
81. Abou Abbass A, Abouljoud M, Yoshida A, et al. Biliary complications after orthotopic liver transplantation from donors after cardiac death: broad spectrum of disease. Transplant Proc 2010;42(9):3392-8
82. Damrah O, Sharma D, Burroughs A, et al. Duct-to-duct biliary reconstruction in orthotopic liver transplantation for primary sclerosing cholangitis: a viable and safe alternative. Transpl Int 2012;25(1):64-8
83. DeOliveira ML, Jassem W, Valente R, et al. Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center. Ann Surg 2011;254(5):716-22. discussion 722-713
84. Esfeh JM, Eghtesad B, Hodgkinson P, et al. Duct-to-duct biliary reconstruction in patients with primary sclerosing cholangitis undergoing liver transplantation. HPB (Oxford) 2011;13(9):651-5
85. Gaman G, Gelley F, Doros A, et al. Biliary complications after orthotopic liver transplantation: the Hungarian experience. Transplant Proc 2013;45(10):3695-7
86. Gilbo N, Mirabella S, Strignano P, et al. External biliary fistula in orthotopic liver transplantation. Transplant Proc 2009;41(4):1316-18
87. Grat M, Kornasiewicz O, Grat K, et al. Short and long-term outcomes after primary liver transplantation in elderly patients. Pol Przegl Chir 2013;85(10):581-8
88. Haberal M, Sevmis S, Karakayali H, et al. Bile duct reconstruction without a stent in liver transplantation: early results of a single center. Transplant Proc 2008;40(1):240-4
89. Hoekstra H, Buis CI, Verdonk RC, et al. Is Roux-en-Y choledochojejunostomy an independent risk factor for nonanastomotic biliary strictures after liver transplantation? Liver Transpl 2009;15(8):924-30
90. Lastovickova J, Peregrin J. Biliary strictures after orthotopic liver transplantation: long-term results of percutaneous treatment in patients with nonfeasible endoscopic therapy. Transplant Proc 2012;44(5):1379-84
91. Lattanzi B, Lai Q, Guglielmo N, et al. Graft macrosteatosis and time of T-tube removal as risk factors for biliary strictures after liver transplantation. Clin Transplant 2013;27(3):E332-8
92. Liu YF, Li GC, Wu G, et al. Prevention and treatment of biliary complications following orthotopic liver transplantation. Zhonghua Wai Ke Za Zhi 2008;46(12):911-13
93. Lopez-Andujar R, Oron EM, Carregnato AF, et al. T-tube or no T-tube in cadaveric orthotopic liver transplantation: the eternal dilemma: results of a prospective and randomized clinical trial. Ann Surg 2013;258(1):21-9
94. Sanna C, Saracco GM, Reggio D, et al. Endoscopic retrograde cholangiopancreatography in patients with biliary complications after orthotopic liver transplantation: outcomes and complications. Transplant Proc 2009;41(4):1319-21
95. Sutton ME, Bense RD, Lisman T, et al. Duct-to-duct reconstruction in liver transplantation for primary sclerosing cholangitis is associated with fewer biliary complications in comparison with hepaticojejunostomy. Liver Transpl 2014; 20(4):457-63
96. Tranchart H, Zalinski S, Sepulveda A, et al. Removable intraductal stenting in duct-to-duct biliary reconstruction in liver transplantation. Transpl Int 2012;25(1):19-24
97. Weiss S, Schmidt SC, Ulrich F, et al. Biliary reconstruction using a side-to-side choledochocholedochostomy with or without T-tube in deceased donor liver transplantation: a prospective randomized trial. Ann Surg 2009;250(5):766-71
98. Welling TH, Heidt DG, Englesbe MJ, et al. Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl 2008;14(1):73-80
99. Yuan D, Wei YG, Lin HM, et al. Risk factors of biliary complications following liver transplantation: retrospective analysis of a single centre. Postgrad Med J 2009;85(1001):119-23
100. Campsen J, Zimmerman MA, Mandell MS, et al. Hepaticoduodenostomy is an alternative to Roux-en-Y hepaticojejunostomy for biliary reconstruction in live donor liver transplantation. Transplantation 2009;87(12):1842-5
101. Chang JH, Lee IS, Choi JY, et al. Biliary Stricture after Adult Right-Lobe Living-Donor Liver Transplantation with Duct-to-Duct Anastomosis: long-Term Outcome and Its Related Factors after Endoscopic Treatment. Gut Liver 2010;4(2):226-33
102. Chok KS, Chan SC, Cheung TT, et al. Bile duct anastomotic stricture after adult-to-adult right lobe living donor liver transplantation. Liver Transpl 2011;17(1):47-52
103. Kim JD, Han YS, Choi DL. Is microsurgical technique useful in biliary reconstruction of living donor liver transplantation? Transplant Proc 2012;44(2):466-8
104. Kirimlioglu V, Tatli F, Ince V, et al. Biliary complications in 106 consecutive duct-to-duct biliary reconstruction in right-lobe living donor liver transplantation performed in 1 year in a single center: a new surgical technique. Transplant Proc 2011;43(3):917-20
105. Kohler S, Pascher A, Mittler J, et al. Management of biliary complications following living donor liver transplantation-a single center experience. Langenbecks Arch Surg 2009;394(6):1025-31
106. Kyoden Y, Tamura S, Sugawara Y, et al. Incidence and management of biliary complications after adult-to-adult living donor liver transplantation. Clin Transplant 2010;24(4):535-42
107. Mizuno S, Inoue H, Tanemura A, et al. Biliary Complications in 108 Consecutive Recipients With Duct-to-Duct Biliary Reconstruction in Living-Donor Liver Transplantation. Transplant Proc 2014;46(3):850-5
108. Park JB, Kwon CH, Choi GS, et al. Prolonged cold ischemic time is a risk factor for biliary strictures in duct-to-duct biliary reconstruction in living donor liver transplantation. Transplantation 2008;86(11):1536-42
109. Saidi RF, Elias N, Ko DS, et al. Biliary reconstruction and complications after living-donor liver transplantation. HPB (Oxford) 2009;11(6):505-9
110. Yaprak O, Dayangac M, Akyildiz M, et al. Biliary complications after right lobe living donor liver transplantation: a single-centre experience. HPB (Oxford) 2012;14(1):49-53
111. Wang MF, Jin ZK, Chen DZ, et al. Risk factors of severe ischemic biliary complications after liver transplantation. Hepatobiliary Pancreat Dis Int 2011;10(4):374-9
112. de Vera ME, Lopez-Solis R, Dvorchik I, et al. Liver transplantation using donation after cardiac death donors: long-term follow-up from a single center. Am J Transplant 2009;9(4):773-81
113. Nemes B, Zadori G, Hartmann E, et al. Biliary complications following orthotopic liver transplantation. The Hungarian experience. Orv Hetil 2008;149(21):963-73
114. Audet M, Panaro F, Piardi T, et al. Passenger lymphocyte syndrome and liver transplantation. Clin Dev Immunol 2008;2008:715769
115. Sun HY, Wagener MM, Singh N. Prevention of posttransplant cytomegalovirus disease and related outcomes with valganciclovir: a systematic review. Am J Transplant 2008;8(10):2111-18
116. Kim SI, Kim CJ, Kim YJ, et al. Antiviral prophylaxis versus preemptive therapy to prevent cytomegalovirus infection and related death in liver transplantation: a retrospective study with propensity score matching. Transplant Proc 2012;44(3):787-90
117. Razonable RR. Cytomegalovirus infection after liver transplantation: current concepts and challenges. World J Gastroenterol 2008;14(31):4849-60